BC
OGN icon

Burleson & Co’s Organon & Co OGN Stock Holding History

Burleson & Co’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$10.3K Hold
368
– – ﹤0.01% 267
2022
Q3 		$9K Buy
368
+1
+0.3% +$30 ﹤0.01% 289
2022
Q2 		$12K Sell
367
-20
-5% -$701 ﹤0.01% 256
2022
Q1 		$14K Sell
387
-10
-3% -$342 ﹤0.01% 253
2021
Q4 		$12K Sell
397
-884
-69% -$28.8K ﹤0.01% 255
2021
Q3 		$42K Hold
1,281
– – 0.01% 197
2021
Q2 		$39K Buy
+1,281
New +$42.2K 0.01% 208

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Burleson & Co's OGN Position: Q4 2022 in Review

Burleson & Co held its Organon & Co (OGN) position steady in Q4 2022 at 368 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Burleson & Co first reported a position in OGN in Q2 2021 and has held it in 7 quarters since. The position peaked at $42K in Q3 2021. 823 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Burleson & Co held 368 shares of Organon & Co worth $10.3K as of Q4 2022.
  • Burleson & Co left its Organon & Co share count unchanged in Q4 2022.
  • Organon & Co made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #267 holding.
  • Burleson & Co first reported a position in Organon & Co in Q2 2021 and has held it in 7 quarters since.
  • Burleson & Co's Organon & Co position peaked at $42K in Q3 2021.
  • 823 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.